Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,118 | -1,017 | -837 | -7,572 | -3,699 |
| Depreciation Amortization | N/A | N/A | N/A | 279 | 137 |
| Other Working Capital | 960 | 914 | 714 | 1,538 | 1,264 |
| Other Operating Activity | -6 | -35 | -21 | 3,894 | 509 |
| Operating Cash Flow | $-164 | $-138 | $-145 | $-1,862 | $-1,790 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 2 | 2 |
| Net Acquisitions | N/A | N/A | N/A | 23 | 23 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $25 | $25 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 40 | 25 | N/A | 400 | 400 |
| Other Financing Activity | -19 | -13 | 0 | -21 | -21 |
| Financing Cash Flow | $21 | $12 | $N/A | $378 | $378 |
| Beginning Cash Position | 152 | 152 | 152 | 1,611 | 1,611 |
| End Cash Position | 10 | 26 | 8 | 152 | 224 |
| Net Cash Flow | $-142 | $-127 | $-145 | $-1,459 | $-1,387 |
| Free Cash Flow | |||||
| Operating Cash Flow | -164 | -138 | -145 | -1,862 | -1,790 |
| Capital Expenditure | N/A | N/A | N/A | -5 | -5 |
| Free Cash Flow | -164 | -138 | -145 | -1,867 | -1,795 |